Clinical Trial Update: A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial of RO6811135 in patients with Type 2 diabetes mellitus inadequately controlled with metformin has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• RO6811135

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 2 | Status: WITHDRAWN